Recombinant SARS-CoV-2 S-stable trimer Protein (C-6His)
Recombinant SARS-CoV-2 S-stable trimer Protein (C-6His) supplied by Elabscience with collaborator-provided technical specifications. Read more ›
["Immobilized 2019-nCoV S-trimer Protein-His(PKSV030314) at 2μg/ml (100 μl/well) can bind Human ACE-2-Fc(PKSR030492). The ED50 of Human ACE-2-Fc(PKSR030492) is 23.83 ng/ml, Immobilized 2019-nCoV S-trimer Protein-His(PKSV030314) at 2μg/ml (100 μl/well) can bind Anti-2019-nCoV S1 mAb (5D9). The ED50 of Anti-2019-nCoV S1 mAb (5D9) is 15.44 ng/ml. ,170-220 kDa"]Product Description
SARS-CoV-2 S-stable trimer is the stated recombinant protein target for this Elabscience product. The listing uses collaborator-supplied specifications to support research-use-only protein selection through ABMIUM.
Protein profile: reactive species/source: SARS-CoV-2; expression system: HEK293 Cells; physical form: Supplied as a 0.2 μm filtered solution of PBS, 5% Trehalose, 10% Glycerol, 5% Mannitol, 0.01% Tween 80, pH 7.4.; tag: SARS-CoV-2 ,SARS-CoV-2 S-stable trimer ,Recombinant Proteins; predicted molecular weight: 136.6 kDa.
Quality and formulation: purity: > 95 % as determined by reducing SDS-PAGE.; concentration: Subject to label value..
Functional evidence: activity: Immobilized 2019-nCoV S-trimer Protein-His(PKSV030314) at 2μg/ml (100 μl/well) can bind Human ACE-2-Fc(PKSR030492). The ED<sub>50</sub> of Human ACE-2-Fc(PKSR030492) is 23.83 ng/ml, Immobilized 2019-nCoV S-trimer Protein-His(PKSV030314) at 2μg/ml (100 μl/well) can bind Anti-2019-nCoV S1 mAb (5D9). The ED<sub>50</sub> of Anti-2019-nCoV S1 mAb (5D9) is 15.44 ng/ml.. In the ABMIUM matrix, collaborator-supplied functional evidence is marked C; unsupported application columns remain N.
Sequence coverage: 136.6 kDa.
Database references: UniProt: QHD43416.1 | NCBI Gene: 43740568 | Gene symbol: SARS-CoV-2 S-stable trimer.
Research Use Only.
Key Facts
| Target | SARS-CoV-2 S-stable trimer |
| Also known as | SARS-CoV-2 S glycoprotein, SARS-CoV-2 S-stable trimer Protein, SARS-CoV-2 Spike, SARS-CoV-2 Spike glycoprotein |
| Concentration | Subject to label value. |
| Species reactivity | SARS-CoV-2 |
| Purity | > 95 % as determined by reducing SDS-PAGE. |
| Form / buffer | Supplied as a 0.2 μm filtered solution of PBS, 5% Trehalose, 10% Glycerol, 5% Mannitol, 0.01% Tween 80, pH 7.4. |
| Shelf life | 6 months |
| BIOACTIVITY | BINDING | CELL-BASED | IN VIVO | ELISA CAPTURE | |
|---|---|---|---|---|---|
| SARS-CoV-2 |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.